BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Sarcomas AND PRF1, P14222, PFP, P1, MGC65093, HPLH2, FLH2, ENSG00000180644, 5551 AND Treatment
19 results:

  • 1. Survival comparison of first-line treatment regimens in patients with braf-mutated advanced colorectal cancer: a multicenter retrospective study.
    Meng Q; Zhao J; Yu Y; Wang K; Ren J; Xu C; Wang Y; Wang G
    BMC Cancer; 2023 Feb; 23(1):191. PubMed ID: 36849918
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Single-cell RNA-sequencing dissects cellular heterogeneity and identifies two tumor-suppressing immune cell subclusters in HPV-related cervical adenosquamous carcinoma.
    Li X; Zhang M; Lei T; Zou W; Huang R; Wang F; Huang Q; Wang C; Liu C
    J Med Virol; 2022 Dec; 94(12):6047-6059. PubMed ID: 36000446
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Efficacy and safety of regorafenib in patients with metastatic or locally advanced chondrosarcoma: Results of a non-comparative, randomised, double-blind, placebo controlled, multicentre phase II study.
    Duffaud F; Italiano A; Bompas E; Rios M; Penel N; Mir O; Piperno-Neumann S; Chevreau C; Delcambre C; Bertucci F; Boudou-Rouquette P; Cancel M; Perrin C; Saada-Bouzid E; Monard L; Schiffler C; Chaigneau L; Hervieu A; Collard O; Bouvier C; Vidal V; Chabaud S; Blay JY;
    Eur J Cancer; 2021 Jun; 150():108-118. PubMed ID: 33895682
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. The Role of Chemotherapy in Extraskeletal Osteosarcoma: A Propensity Score Analysis of the Surveillance Epidemiology and End Results (SEER) Database.
    Qi L; Wan L; Ren X; Zhang W; Tu C; Li Z
    Med Sci Monit; 2020 Aug; 26():e925107. PubMed ID: 32792473
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Carcinosarcoma of the prostate: case report with molecular and histological characterization.
    Salvi S; Casadio V; Martignano F; Gurioli G; Tumedei MM; Calistri D; Gunelli R; Costantini M
    Int J Biol Markers; 2018 Nov; 33(4):540-544. PubMed ID: 30101629
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Paclitaxel Given Once Per Week With or Without Bevacizumab in Patients With Advanced Angiosarcoma: A Randomized Phase II Trial.
    Ray-Coquard IL; Domont J; Tresch-Bruneel E; Bompas E; Cassier PA; Mir O; Piperno-Neumann S; Italiano A; Chevreau C; Cupissol D; Bertucci F; Bay JO; Collard O; Saada-Bouzid E; Isambert N; Delcambre C; Clisant S; Le Cesne A; Blay JY; Penel N
    J Clin Oncol; 2015 Sep; 33(25):2797-802. PubMed ID: 26215950
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Mixed adenoneuroendocrine carcinoma of the colon: molecular pathogenesis and treatment.
    Vanacker L; Smeets D; Hoorens A; Teugels E; Algaba R; Dehou MF; De Becker A; Lambrechts D; De Greve J
    Anticancer Res; 2014 Oct; 34(10):5517-21. PubMed ID: 25275049
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Prognostic value of PLAGL1-specific CpG site methylation in soft-tissue sarcomas.
    Peille AL; Brouste V; Kauffmann A; Lagarde P; Le Morvan V; Coindre JM; Chibon F; Bresson-Bepoldin L
    PLoS One; 2013; 8(11):e80741. PubMed ID: 24260468
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. An open-label, phase 2 study evaluating the efficacy and safety of the anti-IGF-1R antibody cixutumumab in patients with previously treated advanced or metastatic soft-tissue sarcoma or Ewing family of tumours.
    Schöffski P; Adkins D; Blay JY; Gil T; Elias AD; Rutkowski P; Pennock GK; Youssoufian H; Gelderblom H; Willey R; Grebennik DO
    Eur J Cancer; 2013 Oct; 49(15):3219-28. PubMed ID: 23835252
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Targeting GSTP1-1 induces JNK activation and leads to apoptosis in cisplatin-sensitive and -resistant human osteosarcoma cell lines.
    Sau A; Filomeni G; Pezzola S; D'Aguanno S; Tregno FP; Urbani A; Serra M; Pasello M; Picci P; Federici G; Caccuri AM
    Mol Biosyst; 2012 Apr; 8(4):994-1006. PubMed ID: 22068640
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Imatinib for progressive and recurrent aggressive fibromatosis (desmoid tumors): an FNCLCC/French Sarcoma Group phase II trial with a long-term follow-up.
    Penel N; Le Cesne A; Bui BN; Perol D; Brain EG; Ray-Coquard I; Guillemet C; Chevreau C; Cupissol D; Chabaud S; Jimenez M; Duffaud F; Piperno-Neumann S; Mignot L; Blay JY
    Ann Oncol; 2011 Feb; 22(2):452-7. PubMed ID: 20622000
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Analysis of an alternative human CD133 promoter reveals the implication of Ras/ERK pathway in tumor stem-like hallmarks.
    Tabu K; Kimura T; Sasai K; Wang L; Bizen N; Nishihara H; Taga T; Tanaka S
    Mol Cancer; 2010 Feb; 9():39. PubMed ID: 20167130
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Pazopanib, a multikinase angiogenesis inhibitor, in patients with relapsed or refractory advanced soft tissue sarcoma: a phase II study from the European organisation for research and treatment of cancer-soft tissue and bone sarcoma group (EORTC study 62043).
    Sleijfer S; Ray-Coquard I; Papai Z; Le Cesne A; Scurr M; Schöffski P; Collin F; Pandite L; Marreaud S; De Brauwer A; van Glabbeke M; Verweij J; Blay JY
    J Clin Oncol; 2009 Jul; 27(19):3126-32. PubMed ID: 19451427
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Adenosine inhibition of lipopolysaccharide-induced interleukin-6 secretion by the osteoblastic cell line MG-63.
    Russell JM; Stephenson GS; Yellowley CE; Benton HP
    Calcif Tissue Int; 2007 Oct; 81(4):316-26. PubMed ID: 17705048
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Brostallicin, an agent with potential activity in metastatic soft tissue sarcoma: a phase II study from the European Organisation for Research and treatment of Cancer Soft Tissue and Bone Sarcoma Group.
    Leahy M; Ray-Coquard I; Verweij J; Le Cesne A; Duffaud F; Hogendoorn PC; Fowst C; de Balincourt C; di Paola ED; van Glabbeke M; Judson I; Blay JY;
    Eur J Cancer; 2007 Jan; 43(2):308-15. PubMed ID: 17095209
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. HNK-1 carbohydrate-mediated cell adhesion to laminin-1 is different from heparin-mediated and sulfatide-mediated cell adhesion.
    Hall H; Deutzmann R; Timpl R; Vaughan L; Schmitz B; Schachner M
    Eur J Biochem; 1997 May; 246(1):233-42. PubMed ID: 9210489
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Domain-specific activation of neuronal migration and neurite outgrowth-promoting activities of laminin.
    Calof AL; Campanero MR; O'Rear JJ; Yurchenco PD; Lander AD
    Neuron; 1994 Jul; 13(1):117-30. PubMed ID: 8043273
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. [Effects of plant polysaccharide paliustran on the growth of human tumor transplants in athymic mice].
    Bukharova IK; Osokina LI; Revazova ES; Moroz LV
    Vopr Onkol; 1990; 36(4):448-51. PubMed ID: 2345993
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. The treatment of soft-tissue sarcomas of the extremities: prospective randomized evaluations of (1) limb-sparing surgery plus radiation therapy compared with amputation and (2) the role of adjuvant chemotherapy.
    Rosenberg SA; Tepper J; Glatstein E; Costa J; Baker A; Brennan M; DeMoss EV; Seipp C; Sindelar WF; Sugarbaker P; Wesley R
    Ann Surg; 1982 Sep; 196(3):305-15. PubMed ID: 7114936
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.